Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma

Clinical trial NCT01149122 · COMPLETED

Trial details

NCT number: NCT01149122
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Unresectable, Metastatic Biliary Tract Carcinoma

Start date: 2009-01-01
Primary completion: 2012-01-01
Enrollment: 266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.